iX Biopharma Ltd. | Mutual Funds
Mutual Funds that own iX Biopharma Ltd.
3,667,917
0.56%
-444,549
3.03%
11/20/2017
NPB SICAV - NPB Asia (ex-Japan)
2,272,700
0.35%
0
1.77%
12/31/2017
Pheim Asia (ex-Japan) Fund
569,920
0.09%
0
1.59%
06/30/2017
Pheim Master Trust - Pheim Emerging Companies Balanced Fd.
556,400
0.09%
0
0.97%
06/30/2017
Pheim Asia (ex-Japan) Islamic Fund
243,360
0.04%
0
1.52%
06/30/2017
Pheim Master Trust - Pheim Income Fund
104,000
0.02%
0
0.57%
06/30/2017
| Address |
1 Kim Seng Promenade, No. 14-01
Singapore CE 237994
Singapore
|
|
Employees
|
- |
| Website |
http://www.ixbiopharma.com |
| Updated |
07/08/2019 |
| iX Biopharma Ltd. engages in the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, as well as male erectile dysfunction. It operates through the following segments: Specialty Pharmaceutical and Chemical Analysis. The Specialty Pharmaceutical segment manufactures and sells pharmaceutical products. |
